BioCentury
ARTICLE | Financial News

Immune Design amends IPO

July 21, 2014 7:00 AM UTC

Immune Design Corp., Seattle, Wash. Business: Infectious, Cancer Date announced: 2014-07-14 Type: IPO To be raised: Up to $65.1 million Shares: 4.7 million Price: $12-$14 Underwriters: Jefferies; Leer...